People: Alkermes Plc (ALKS.O)

ALKS.O on Nasdaq

61.70USD
20 Apr 2015
Change (% chg)

$-1.09 (-1.74%)
Prev Close
$62.79
Open
$63.07
Day's High
$63.09
Day's Low
$61.11
Volume
621,232
Avg. Vol
1,425,754
52-wk High
$75.17
52-wk Low
$38.49

Search Stocks

Breyer, Robert 

Mr. Robert A. Breyer is an Independent Director of Alkermes Plc. From July 1994 to September 16, 2011, Mr. Breyer served on the Alkermes, Inc. board of directors. He served as the President of Alkermes, Inc. from July 1994 until his retirement in December 2001 and Chief Operating Officer from July 1994 to February 2001. Prior to that time, Mr. Breyer was an executive and held various positions in the global pharmaceutical and medical device industries, including general manager of Eli Lilly Benelux S.A and Eli Lilly Italia S.p.A. Mr. Breyer also served on the board of directors of Lentigen, Inc., a privately held, diversified biology company from 2007 to 2009. Mr. Breyer's experience as an executive in the pharmaceutical and medical device industries provides management and operational skills to our Board. Mr. Breyer has experience with managing the overall financial performance of pharmaceutical and medical device units and in pharmaceutical manufacturing and sales and marketing operations. As a former executive at Alkermes, Inc., Mr. Breyer also has first-hand knowledge of our technology, manufacturing operations, research and development and management team.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Richard Pops

8,696,650

Shane Cooke

3,912,100

James Frates

2,095,130

Gordon Pugh

1,965,720

Kathryn Biberstein

2,488,720

Rebecca Peterson

--
As Of  30 Mar 2014
Search Stocks